Azafaros Starts Phase 3 Trials for Rare Neuro Disorders
Azafaros, a company focused on developing treatments for the unmet needs of patients with rare lysosomal storage disorders, today announced that the first patient has...
Category : Healthcare and Pharmaceutical
MaaT Pharma Secures €37.5M EIB Loan for Cancer Pipeline
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapies™ (MET) dedicated to enhancing survival...
Biocytogen Expands Preclinical Services, Updates Website
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies,...
BeOne’s TEVIMBRA Gets CHMP Nod for NSCLC Treatment
Recommendation based on Phase 3 RATIONALE-315 study, in which TEVIMBRA demonstrated clinically meaningful and statistically significant improvement in event-free survival and major pathological response If...
NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation
Two transformative healthcare announcements this week mark a new era for New Jersey’s innovation economy—with Garden State Venture Partners (GSVP) emerging as a key catalyst...
Sanofi’s Sarclisa Approved in EU for New Multiple Myeloma
Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Following the positive opinion by the European Medicines Agency’s Committee for Medicinal Products...
Abivax Raises $747.5M with Full ADS Offering Exercise
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) Abivax SA (Euronext Paris: FR0012333284 –...
Pfizer & BioNTech Get Positive EU Opinion for COVID Vaccine
Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
Singapore Start-Up Makes Strategic Move into China Med-Tech
Syntellix AG, parent company of Singapore-based, Syntellix Asia Pte Ltd, has received product approval for the People’s Republic of China from the Chinese NMPA (National Medical Products Administration)...
Kling Bio Partners with Sanofi to Boost Antibody Discovery
Kling Bio (“Kling” or “the Company”), a biotech company developing antibody-based drugs for cancer and infectious diseases, today announced it has entered into a collaboration and...
iOnctura Adds Two Experts to Board for Medical Growth
iOnctura, a clinical-stage precision oncology company combating neglected and hard-to-treat cancers, today announces the appointment of two Non-Executive Directors to its Board. Joining the Board...
Malaysia Launches MYMT 2026, Its 1st Medical Tourism Year
The Malaysia Healthcare Travel Council (MHTC) launched Malaysia Year of Medical Tourism (MYMT) 2026 today at the Malaysia International Trade and Exhibition Centre (MITEC). The Honourable Datuk...
Flatiron Health Triples Global Oncology Research Network
Flatiron Health’s expanded partnerships fuel real-world data research to transform cancer care across Europe and Asia Flatiron Health, a leading healthtech company dedicated to improving...
Vida Health Adds Execs to Drive Growth in Heart & Metabolic Care
Alongside a recent capital raise, the company announced Chief Strategy Officer Jason Macaleer will partner with Chief Growth Officer Mike Rolla to meet growing demand...
Oliva Therapeutics Launches Thyquidity® Oral Solution
Oliva Therapeutics, a US-based healthcare company focused on product commercialization, sales, marketing, distribution, and promotion, announced today the relaunch and immediate availability of Thyquidity® (Levothyroxine...